Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to Reevaluate their Toxicity

E-ISSN： 1875-533x|18|14|2186-2195

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.14, 2011-05, pp. : 2186-2195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M. Morrison I.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite

The Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Children with HIV-1 Infection

By Maddocks S. Dwyer D.

Pediatric Drugs, Vol. 3, Iss. 9, 2001-01 ,pp. : 681-702

Adis International

Access to resources Recommend Favorite

Synthesis and Anti-HIV Evaluation of Novel 1,2,4-triazole Derivatives as Potential Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors

Letters in Drug Design & Discovery, Vol. 10, Iss. 1, 2013-01 ,pp. : 27-34

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Treating HIV-Infected Children

By Penazzato Martina Giaquinto Carlo

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2131-2149

Adis International

Access to resources Recommend Favorite